IERA Quirónsalud is a pioneer in Assisted Reproduction techniques in the Extremadura region of Spain. Established in 2000, the institute specializes in providing advanced medical and biological techniques to address infertility issues faced by couples. Its focus on personalized treatments and utilization of cutting-edge medical and biological procedures sets it apart in the industry.
Having achieved significant milestones, IERA Quirónsalud proudly witnessed the birth of the first child through In Vitro Fertilization (FIV) in 2000, followed by the births of the first children from frozen embryos and egg donation in 2001. In 2002, the institute accomplished another breakthrough with the birth of the first child through testicular biopsy.
The ultimate success of any technique is measured by the birth of a healthy child, and IERA Quirónsalud is committed to minimizing the risks associated with multiple pregnancies, prioritizing the well-being of both mothers and newborns. As a Health Care startup based in Spain, IERA Quirónsalud presents an innovative approach to addressing infertility and reproductive healthcare needs, making it an impactful player in the field. With no available information on the last investment or investors, the institute's future developments and potential influencers remain to be seen.
There is no investment information
No recent news or press coverage available for IERA Quirónsalud.
We care about your data, and we'd love to use cookies make your experience better.
